Autonomic nervous system control of the cardiovascular and respiratory systems in asthma.

Patients with asthma have exaggerated bronchoconstriction of their airways in response to certain indirect (e.g. cold air, allergens, dust, exercise) or direct (e.g. inhaled methacholine) stimuli. This 'hyper-reactivity' usually co-exists with airway inflammation, although the pathophysiological mechanisms underlying these changes are not fully understood. It is likely that this hyper-reactivity is associated with abnormal autonomic nervous system (ANS) control. In particular, the parasympathetic (vagal) component of the ANS appears to be implicated in the pathogenesis of asthma. In addition, several studies have suggested the existence of differential alteration in ANS function following exercise in asthmatics compared with non-asthmatic individuals. Several early studies suggested that the altered autonomic control of airway calibre in asthma might be reflected by a parallel change in heart rate. Cardiac vagal reactivity does indeed appear to be increased in asthma, as demonstrated by the cardiac response to various autonomic functions tests. However, other studies have reported a lack of association between bronchial and cardiac vagal tone, and this is in accord with the concept of system-independent ANS control. This review provides a discussion of cardiovascular-autonomic changes associated with either the pathophysiology of asthma per se or with asthma pharmacotherapy treatment. Previous investigations are summarised suggesting an apparent association between altered autonomic-cardiovascular control and bronchial asthma. The full extent of autonomic dysfunction, and its clinical implications, has yet to be fully determined and should be the subject of future investigation.

[1]  A. Tattersfield,et al.  The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. , 1999, The European respiratory journal.

[2]  E. R. Mcfadden,et al.  Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. , 1986, The Journal of clinical investigation.

[3]  R. Cohen,et al.  Hemodynamic regulation: investigation by spectral analysis. , 1985, The American journal of physiology.

[4]  K. Belmonte Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.

[5]  J. V. van Vlymen,et al.  The Duration of Impairment of Autonomic Control After Anticholinergic Drug Administration in Humans , 1997, Anesthesia and analgesia.

[6]  W. C. Randall,et al.  SA nodal parasympathectomy delineates autonomic control of heart rate power spectrum. , 1991, The American journal of physiology.

[7]  B. Canning,et al.  Regulation of baseline cholinergic tone in guinea‐pig airway smooth muscle , 1999, The Journal of physiology.

[8]  H. Huikuri,et al.  Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns. , 2001, Clinical physiology.

[9]  R. Pierson,et al.  Mechanism of bronchoconstriction due to beta adrenergic blockade. Studies with practolol, propranolol, and atropine. , 1971, The Journal of allergy and clinical immunology.

[10]  K. Hirata,et al.  Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. , 2000, The Journal of allergy and clinical immunology.

[11]  A. Porta,et al.  Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. , 1994, Circulation.

[12]  J. Nadel Autonomic control of airway smooth muscle and airway secretions. , 1977, The American review of respiratory disease.

[13]  W. Busse Pathogenesis and pathophysiology of nocturnal asthma. , 1988, The American journal of medicine.

[14]  J. Kline,et al.  Vitamin A deficiency promotes bronchial hyperreactivity in rats by altering muscarinic M(2) receptor function. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[15]  M. Turiel,et al.  Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.

[16]  A. Koziell,et al.  Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade. , 1984, The Journal of physiology.

[17]  J. Schwartz,et al.  β‐Adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding , 1983 .

[18]  F. Crea,et al.  Effects of beta2-adrenoceptor stimulation on exercise-induced myocardial ischemia , 1991 .

[19]  P. Howarth,et al.  Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. , 2001, Thorax.

[20]  J. Crane,et al.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals , 2004, European Journal of Clinical Pharmacology.

[21]  A. Pappano,et al.  The parasympathetic neuroeffector junction of the heart. , 1985, Pharmacological reviews.

[22]  M. Koulu,et al.  Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. , 1987, British journal of clinical pharmacology.

[23]  H. Dean,et al.  Parasympathetic nervous system in nocturnal asthma , 1988, British medical journal.

[24]  C. Dollery,et al.  Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma , 1980, Nature.

[25]  E. R. Mcfadden,et al.  Exhaled nitric oxide and thermally induced asthma. , 2001, American journal of respiratory and critical care medicine.

[26]  M. Kaliner The cholinergic nervous system and immediate hypersensitivity. 1. Eccrine sweat responses in allergic patients. , 1976, The Journal of allergy and clinical immunology.

[27]  N. Gross,et al.  Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent. , 1987, The American review of respiratory disease.

[28]  T. Kuusela,et al.  The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. , 1998, British journal of clinical pharmacology.

[29]  B. Silke,et al.  Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods. , 1999, British journal of clinical pharmacology.

[30]  P. Barnes,et al.  Autonomic regulation of the airways. , 1984, Annual review of medicine.

[31]  P. O'Byrne,et al.  Methacholine airway responsiveness decreases during exercise in asthmatic subjects. , 1990, The American review of respiratory disease.

[32]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[33]  D. Jacoby Virus-induced asthma attacks. , 2002, JAMA.

[34]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[35]  A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. , 1987, The Journal of allergy and clinical immunology.

[36]  N. Pearce,et al.  PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.

[37]  G. Gleich,et al.  Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[38]  A. Wellstein,et al.  Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[39]  P. Macklem,et al.  Distribution of regional ventilation measured by breath sounds. , 1978, The American review of respiratory disease.

[40]  R. Kleiger Heart Rate Variability and Mortality and Sudden Death Post Infarction , 1995, Journal of cardiovascular electrophysiology.

[41]  F. Leenen,et al.  Hemodynamic effects of an inhaled beta‐2 agonist , 1984, Clinical pharmacology and therapeutics.

[42]  P. Sterk,et al.  Cardiovascular side e V ects of inhaled salbutamol in hypoxic asthmatic patients , 2001 .

[43]  R. Creasy,et al.  Cardiovascular complications associated with terbutaline treatment for preterm labor. , 1981, American journal of obstetrics and gynecology.

[44]  S. Pearson,et al.  The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma. , 1989, British journal of clinical pharmacology.

[45]  Ultan McDermott,et al.  Time and frequency domain assessment of heart rate variability: A theoretical and clinical appreciation , 1993, Clinical Autonomic Research.

[46]  P. Barnes Neural mechanisms in asthma. , 1992, British medical bulletin.

[47]  J. Shelhamer,et al.  Autonomic nervous system abnormalities and allergy. , 1982, Annals of internal medicine.

[48]  S. Jennings,et al.  Effect of adrenergic and vagal blockade on the normal human airway response to exercise. , 1983, Clinical science.

[49]  S. Scalvini,et al.  Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[50]  M. Silverman,et al.  Circulating catecholamines in exercise and hyperventilation induced asthma. , 1981, Thorax.

[51]  D. Lipson,et al.  Opposing central and peripheral effects of atropine on parasympathetic cardiac control. , 1977, The American journal of physiology.

[52]  Mary Jane Thomassen,et al.  Regulation of No Synthesis Transcriptional and Post-translational Oxide (no) in Asthma: Evidence for Molecular Mechanisms of Increased Nitric , 2013 .

[53]  Casale Tb Neuromechanisms of asthma. , 1987, Annals of allergy.

[54]  J. V. van Noord,et al.  A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .

[55]  R. Cohen,et al.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.

[56]  P. Barnes,et al.  Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. , 1991, European journal of pharmacology.

[57]  T. Kuusela,et al.  Cardiovascular autonomic regulation in asthmatic children evidenced by spectral analysis of heart rate and blood pressure variability. , 1996, Scandinavian journal of clinical and laboratory investigation.

[58]  A Malliani,et al.  Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. , 1994, The American journal of cardiology.

[59]  Arthur S Slutsky,et al.  Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects. , 1993, The American review of respiratory disease.

[60]  M. Kollai,et al.  Relation between baroreflex sensitivity and cardiac vagal tone in humans. , 1994, The American journal of physiology.

[61]  L. Fabbri,et al.  Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. , 1999, American journal of respiratory and critical care medicine.

[62]  P. Bjerregaard,et al.  Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. , 1993, The American journal of cardiology.

[63]  C. Sartori,et al.  Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. , 1997, Circulation.

[64]  P. Devillier,et al.  Inhibition by SR 59119A of isoprenaline-, forskolin- and VIP-induced relaxation of human isolated bronchi. , 2000, Pulmonary pharmacology & therapeutics.

[65]  Nieminen,et al.  Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart‐rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease , 1998, Journal of internal medicine.

[66]  M. Lesh,et al.  Autonomic nervous system and sudden cardiac death. , 1996, Journal of the American College of Cardiology.

[67]  J M Kallenbach,et al.  Reflex heart rate control in asthma. Evidence of parasympathetic overactivity. , 1985, Chest.

[68]  L. Cesar Freqüência cardíaca e risco cardiovascular , 2007 .

[69]  S. Julius,et al.  Heart rate and the cardiovascular risk , 1997, Journal of hypertension.

[70]  M. Palmisano,et al.  Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder Inhalation via aerolizerTM , 1999, European Journal of Clinical Pharmacology.

[71]  K. Austen,et al.  IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG , 1971, The Journal of experimental medicine.

[72]  E. Salpeter,et al.  Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.

[73]  B. Lipworth,et al.  Evaluation of partial β‐adrenoceptor agonist activity , 1997 .

[74]  Blunted sympathoadrenal response to exercise in asthmatic subjects. , 1982, British journal of diseases of the chest.

[75]  K. M. Spyer Central nervous integration of cardiovascular control. , 1982, The Journal of experimental biology.

[76]  D. Adam,et al.  Assessment of autonomic function in humans by heart rate spectral analysis. , 1985, The American journal of physiology.

[77]  B. Canning,et al.  Neural regulation of airway smooth muscle tone. , 2001, Respiration physiology.

[78]  H. Scheinin,et al.  Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs. , 1999, Therapeutic drug monitoring.

[79]  T. Kuusela,et al.  Nonlinear methods of biosignal analysis in assessing terbutaline-induced heart rate and blood pressure changes. , 2002, American journal of physiology. Heart and circulatory physiology.

[80]  A. Malliani,et al.  Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.

[81]  M. Seishima,et al.  Autonomic regulation after exercise evidenced by spectral analysis of heart rate variability in asthmatic children. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[82]  J. Crane,et al.  The extrapulmonary effects of increasing doses of formoterol in patients with asthma , 1998, European Journal of Clinical Pharmacology.

[83]  A. Mistretta,et al.  Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. , 1992, The European respiratory journal.

[84]  A Malliani,et al.  Circadian variation of spectral indices of heart rate variability after myocardial infarction. , 1992, American heart journal.

[85]  J. Lundberg,et al.  Pulmonary effects of endogenous and exogenous nitric oxide in the pig: relation to cigarette smoke inhalation , 1993, British journal of pharmacology.

[86]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[87]  A. Tattersfield,et al.  Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. , 1997, Thorax.

[88]  K. Chung,et al.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma , 2000, Thorax.

[89]  Y. Jammes,et al.  Assessment of the pulmonary origin of bronchoconstrictor vagal tone , 1979, The Journal of physiology.

[90]  P. Manglick,et al.  Systemic absorption of salbutamol following nebulizer delivery in acute asthma , 1993, Acta paediatrica.

[91]  K. Sommers,et al.  Possible mechanisms of anti-cholinergic drug-induced bradycardia , 2004, European Journal of Clinical Pharmacology.

[92]  A. Teisman,et al.  Dysfunctional muscarinic M2 autoreceptors in vagally induced bronchoconstriction of conscious guinea pigs after the early allergic reaction. , 1996, European journal of pharmacology.

[93]  T. Kuusela,et al.  Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children. , 1998, Clinical physiology.

[94]  J. Nadel,et al.  Reflex effects of upper airway irritation on total lung resistance and blood pressure. , 1962, Journal of applied physiology.

[95]  P. Corris,et al.  Nebulised salbutamol and angina. , 1982, British medical journal.

[96]  A. Tattersfield,et al.  Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects , 2000, Thorax.

[97]  D. Eckberg,et al.  Important influence of respiration on human R-R interval power spectra is largely ignored. , 1993, Journal of applied physiology.

[98]  I. Horváth,et al.  Relation between bronchial and cardiac vagal tone in healthy humans. , 1995, Chest.

[99]  D. Flenley,et al.  Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. , 1976, British medical journal.

[100]  Y. Donchin,et al.  Spectral analysis of fetal heart rate in sheep: the occurrence of respiratory sinus arrhythmia. , 1984, American journal of obstetrics and gynecology.

[101]  P. Lehrer,et al.  Effects of aerosol ipratropium bromide on cardiac vagal tone. , 1994, Chest.

[102]  B. Lipworth,et al.  Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers. , 1995, British journal of clinical pharmacology.

[103]  R. Tarazi,et al.  Assessment of parasympathetic control of heart rate by a noninvasive method. , 1984, The American journal of physiology.

[104]  M. Ennis,et al.  Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. , 1998, Thorax.

[105]  Webster Dc,et al.  Drug therapy: Bronchodilator therapy (first of two parts). , 1977 .

[106]  J. Widdicombe,et al.  REFLEX CONTROL OF AIRWAY SIZE * , 1963, Annals of the New York Academy of Sciences.

[107]  J. Bradshaw,et al.  Medical audit , 1975, The Lancet.

[108]  S. Macleod,et al.  Anti-Allergy and Anti-Asthma Drugs , 1989, Clinical pharmacokinetics.

[109]  G. Anderson,et al.  Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. , 2000, American journal of respiratory and critical care medicine.

[110]  K. Ashutosh,et al.  Nitric oxide and asthma: a review. , 2000, Current opinion in pulmonary medicine.

[111]  P. Barnes,et al.  Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. , 1985, The American review of respiratory disease.

[112]  O. Brodde Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.

[113]  J. Palmer,et al.  Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. , 1977, British medical journal.

[114]  K. Antila,et al.  Effects of glycopyrrolate and atropine on heart rate variability , 1991, Acta anaesthesiologica Scandinavica.

[115]  S. Jain,et al.  Clinical dysautonomia in patients with bronchial asthma. Study with seven autonomic function tests. , 1990, Chest.

[116]  A. Malliani,et al.  Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. , 1990, Circulation.

[117]  M. Hilton,et al.  Endogenous circadian control of the human autonomic nervous system , 2000, Computers in Cardiology 2000. Vol.27 (Cat. 00CH37163).

[118]  A. Seidler,et al.  Spectral analysis of heart rate variability in bronchial asthma , 1992, Clinical Autonomic Research.

[119]  Beat-to-beat variation of the heart rate in children with allergic asthma. , 1985, The Journal of asthma : official journal of the Association for the Care of Asthma.

[120]  H. Ross,et al.  Nitric oxide and cardiac autonomic control in humans. , 2000, Hypertension.

[121]  I. Adcock,et al.  Transcription factors and asthma. , 1998, The European respiratory journal.

[122]  B. Eryonucu,et al.  Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients. , 2001, The European respiratory journal.

[123]  A. Wellstein,et al.  Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. , 1988, The Journal of pharmacology and experimental therapeutics.

[124]  D. Lambert,et al.  Muscarinic receptor subtypes: do they have a place in clinical anaesthesia? , 1995, British journal of anaesthesia.